Literature DB >> 2276765

Evidence that soluble class I antigen in donor serum induces the suppression of heart allograft rejection in rats.

R Sumimoto1, N Kamada.   

Abstract

The effect on heart allograft rejection in the rat of continuous slow infusion of donor MHC type serum is described. DA (RT1a) serum delayed significantly the rejection of PVG.RT1a heart grafts in PVG recipients (p less than 0.01), but did not affect survival of third-party WAG grafts. Grafts at both early and late stages of rejection were prolonged by serum infusion. Removal of soluble class I MHC antigen from DA serum by affinity chromatography on a monoclonal anti-class I antibody column completely abolished the immunosuppressive effect. The results may indicate that soluble class I antigen can act as a specific immunosuppressive agent in allograft rejection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2276765     DOI: 10.1016/0165-2478(90)90179-t

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  4 in total

1.  Expression of heat shock protein 70 blocks thymic differentiation of T cells in transgenic mice.

Authors:  W H Lee; Y M Park; J I Kim; W Y Park; S H Kim; J J Jang; J S Seo
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

2.  The fas and fas ligand pathways in liver allograft tolerance.

Authors:  T L Pan; S Goto; Y C Lin; R Lord; K C Chiang; C Y Lai; Y S Chen; H L Eng; Y F Cheng; T Tatsuma; S Kitano; C L Lin; C L Chen
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

3.  The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion.

Authors:  U Dahmen; H Sun; Y Li; F Fu; A J Demetris; T E Starzl; S Qian; J J Fung
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

4.  HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family.

Authors:  E Nossner; J E Goldberg; C Naftzger; S C Lyu; C Clayberger; A M Krensky
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.